Question

. A nurse is providing patient education about colesevelam [Welchol], a bile acid sequestrant. Which statement made by the patient demonstrates a need for further teaching?

a. "Colesevelam will reduce my levels of low-density lipoprotein."
b. "Colesevelam will augment my statin drug therapy."
c. "I will not have to worry about having as many drug interactions as I did when I took cholestyramine."
d. "I will need to take supplements of fat-soluble vitamins."

Answer 1

The statement 'I will need to take supplements of fat-soluble vitamins' demonstrates a need for further teaching because colesevelam does not typically cause significant malabsorption of fat-soluble vitamins, unlike other bile acid sequestrants.

Step-by-step explanation:

A nurse is providing patient education about colesevelam [Welchol], a bile acid sequestrant. Considering the provided choices, the statement that demonstrates a need for further teaching is: "I will need to take supplements of fat-soluble vitamins." This statement indicates a misconception because unlike some other bile acid sequestrants such as cholestyramine colesevelam has a significantly lower potential to interfere with the absorption of fat-soluble vitamins. Therefore, routine supplementation is not typically required.

While colesevelam does indeed reduce levels of low-density lipoprotein (LDL) can be used to augment statin drug therapy and is associated with fewer drug interactions compared to cholestyramine it does not usually necessitate additional supplementation of fat-soluble vitamins due to its different chemical properties and its less extensive binding to fats and vitamins in the digestive tract.